WEBVTT
Kind: captions
Language: en

00:00:15.109 --> 00:00:17.779 

hello<00:00:16.109> I'm<00:00:16.320> dr.<00:00:16.650> Geordie<00:00:17.010> lundberg<00:00:17.400> editor<00:00:17.699> in

00:00:17.779 --> 00:00:17.789 
hello I'm dr. Geordie lundberg editor in

00:00:17.789 --> 00:00:21.019 
hello I'm dr. Geordie lundberg editor in
chief<00:00:18.060> for<00:00:18.859> the<00:00:19.859> medscape<00:00:20.369> Journal<00:00:20.970> of

00:00:21.019 --> 00:00:21.029 
chief for the medscape Journal of

00:00:21.029 --> 00:00:24.880 
chief for the medscape Journal of
Medicine<00:00:21.949> do<00:00:22.949> you<00:00:23.039> believe<00:00:23.279> in<00:00:23.400> fibromyalgia

00:00:24.880 --> 00:00:24.890 
Medicine do you believe in fibromyalgia

00:00:24.890 --> 00:00:29.509 
Medicine do you believe in fibromyalgia
what<00:00:25.890> is<00:00:26.039> it<00:00:27.380> dr.<00:00:28.380> George<00:00:28.650> griffing<00:00:29.310> a

00:00:29.509 --> 00:00:29.519 
what is it dr. George griffing a

00:00:29.519 --> 00:00:31.250 
what is it dr. George griffing a
professor<00:00:30.029> of<00:00:30.060> medicine<00:00:30.570> and<00:00:30.810> st.<00:00:31.050> Luke's

00:00:31.250 --> 00:00:31.260 
professor of medicine and st. Luke's

00:00:31.260 --> 00:00:33.470 
professor of medicine and st. Luke's
University<00:00:31.380> is<00:00:32.099> also<00:00:32.520> the<00:00:32.759> editor<00:00:32.880> in<00:00:33.120> chief

00:00:33.470 --> 00:00:33.480 
University is also the editor in chief

00:00:33.480 --> 00:00:36.680 
University is also the editor in chief
for<00:00:33.690> internal<00:00:34.320> medicine<00:00:34.800> in<00:00:35.030> emedicine<00:00:36.030> and

00:00:36.680 --> 00:00:36.690 
for internal medicine in emedicine and

00:00:36.690 --> 00:00:39.530 
for internal medicine in emedicine and
he<00:00:37.559> joined<00:00:37.860> us<00:00:38.070> in<00:00:38.100> our<00:00:38.370> studios<00:00:38.790> in<00:00:38.820> New<00:00:39.210> York

00:00:39.530 --> 00:00:39.540 
he joined us in our studios in New York

00:00:39.540 --> 00:00:43.040 
he joined us in our studios in New York
recently<00:00:39.930> to<00:00:40.309> talk<00:00:41.309> about<00:00:41.750> fibromyalgia<00:00:42.750> what

00:00:43.040 --> 00:00:43.050 
recently to talk about fibromyalgia what

00:00:43.050 --> 00:00:46.810 
recently to talk about fibromyalgia what
it<00:00:43.170> is<00:00:43.379> and<00:00:43.770> what<00:00:44.160> it<00:00:44.280> isn't<00:00:44.840> dr.<00:00:45.840> Griffin

00:00:46.810 --> 00:00:46.820 
it is and what it isn't dr. Griffin

00:00:46.820 --> 00:00:49.369 
it is and what it isn't dr. Griffin
think<00:00:47.820> of<00:00:47.940> your<00:00:48.090> last<00:00:48.300> patient<00:00:48.690> with

00:00:49.369 --> 00:00:49.379 
think of your last patient with

00:00:49.379 --> 00:00:52.010 
think of your last patient with
difficult<00:00:49.860> to<00:00:49.890> treat<00:00:50.149> fibromyalgia<00:00:51.149> aren't

00:00:52.010 --> 00:00:52.020 
difficult to treat fibromyalgia aren't

00:00:52.020 --> 00:00:54.560 
difficult to treat fibromyalgia aren't
they<00:00:52.170> all<00:00:52.399> did<00:00:53.399> you<00:00:53.520> refer<00:00:53.789> that<00:00:54.000> patient<00:00:54.449> to<00:00:54.539> a

00:00:54.560 --> 00:00:54.570 
they all did you refer that patient to a

00:00:54.570 --> 00:00:57.920 
they all did you refer that patient to a
Rheumatologist<00:00:55.579> since<00:00:56.579> the<00:00:56.760> 1950s<00:00:57.629> when<00:00:57.840> it

00:00:57.920 --> 00:00:57.930 
Rheumatologist since the 1950s when it

00:00:57.930 --> 00:00:59.680 
Rheumatologist since the 1950s when it
was<00:00:58.050> first<00:00:58.199> described<00:00:58.770> by<00:00:58.859> dr.<00:00:59.309> Graham

00:00:59.680 --> 00:00:59.690 
was first described by dr. Graham

00:00:59.690 --> 00:01:03.290 
was first described by dr. Graham
fibrous<00:01:00.690> itís<00:01:01.140> or<00:01:01.579> fibromyalgia<00:01:02.579> was<00:01:03.059> thought

00:01:03.290 --> 00:01:03.300 
fibrous itís or fibromyalgia was thought

00:01:03.300 --> 00:01:05.420 
fibrous itís or fibromyalgia was thought
to<00:01:03.329> be<00:01:03.510> a<00:01:03.629> rheumatologic<00:01:04.439> disorder<00:01:04.920> because

00:01:05.420 --> 00:01:05.430 
to be a rheumatologic disorder because

00:01:05.430 --> 00:01:07.609 
to be a rheumatologic disorder because
it<00:01:05.549> was<00:01:05.670> characterized<00:01:06.270> by<00:01:06.619> musculoskeletal

00:01:07.609 --> 00:01:07.619 
it was characterized by musculoskeletal

00:01:07.619 --> 00:01:09.980 
it was characterized by musculoskeletal
pain<00:01:07.860> similar<00:01:08.640> to<00:01:08.850> other<00:01:09.030> rheumatologic

00:01:09.980 --> 00:01:09.990 
pain similar to other rheumatologic

00:01:09.990 --> 00:01:13.670 
pain similar to other rheumatologic
diseases<00:01:10.500> in<00:01:11.280> 1990<00:01:12.270> the<00:01:12.689> american<00:01:13.140> college<00:01:13.560> of

00:01:13.670 --> 00:01:13.680 
diseases in 1990 the american college of

00:01:13.680 --> 00:01:16.550 
diseases in 1990 the american college of
rheumatology<00:01:14.600> established<00:01:15.600> diagnostic

00:01:16.550 --> 00:01:16.560 
rheumatology established diagnostic

00:01:16.560 --> 00:01:19.399 
rheumatology established diagnostic
criteria<00:01:17.159> based<00:01:17.460> on<00:01:17.790> the<00:01:18.119> scoring<00:01:18.509> of<00:01:18.810> 18

00:01:19.399 --> 00:01:19.409 
criteria based on the scoring of 18

00:01:19.409 --> 00:01:22.190 
criteria based on the scoring of 18
potential<00:01:20.070> tender<00:01:20.400> points<00:01:20.630> it<00:01:21.630> turns<00:01:21.960> out

00:01:22.190 --> 00:01:22.200 
potential tender points it turns out

00:01:22.200 --> 00:01:24.320 
potential tender points it turns out
however<00:01:22.560> that<00:01:22.979> these<00:01:23.460> tender<00:01:23.880> points<00:01:24.060> have

00:01:24.320 --> 00:01:24.330 
however that these tender points have

00:01:24.330 --> 00:01:27.289 
however that these tender points have
nothing<00:01:24.689> to<00:01:24.810> do<00:01:24.930> with<00:01:25.049> fibromyalgia<00:01:26.299> biopsy

00:01:27.289 --> 00:01:27.299 
nothing to do with fibromyalgia biopsy

00:01:27.299 --> 00:01:29.630 
nothing to do with fibromyalgia biopsy
of<00:01:27.390> the<00:01:27.420> tender<00:01:27.810> points<00:01:27.990> shows<00:01:28.439> no<00:01:28.740> pathologic

00:01:29.630 --> 00:01:29.640 
of the tender points shows no pathologic

00:01:29.640 --> 00:01:31.999 
of the tender points shows no pathologic
changes<00:01:29.670> and<00:01:30.360> numerous<00:01:30.990> studies<00:01:31.439> have<00:01:31.619> not

00:01:31.999 --> 00:01:32.009 
changes and numerous studies have not

00:01:32.009 --> 00:01:34.069 
changes and numerous studies have not
shown<00:01:32.400> any<00:01:32.640> abnormalities<00:01:33.479> in<00:01:34.020> the

00:01:34.069 --> 00:01:34.079 
shown any abnormalities in the

00:01:34.079 --> 00:01:36.819 
shown any abnormalities in the
musculoskeletal<00:01:34.920> tissues<00:01:35.820> that<00:01:36.030> are<00:01:36.090> painful

00:01:36.819 --> 00:01:36.829 
musculoskeletal tissues that are painful

00:01:36.829 --> 00:01:40.100 
musculoskeletal tissues that are painful
current<00:01:37.829> evidence<00:01:38.009> points<00:01:38.700> to<00:01:38.909> a<00:01:39.110> neurologic

00:01:40.100 --> 00:01:40.110 
current evidence points to a neurologic

00:01:40.110 --> 00:01:42.880 
current evidence points to a neurologic
disorder<00:01:40.650> of<00:01:40.829> central<00:01:41.250> pain<00:01:41.490> processing

00:01:42.880 --> 00:01:42.890 
disorder of central pain processing

00:01:42.890 --> 00:01:45.530 
disorder of central pain processing
fibromyalgia<00:01:43.890> patients<00:01:44.149> experience<00:01:45.149> pain

00:01:45.530 --> 00:01:45.540 
fibromyalgia patients experience pain

00:01:45.540 --> 00:01:47.569 
fibromyalgia patients experience pain
differently<00:01:45.840> and<00:01:46.320> have<00:01:46.380> lower<00:01:47.220> pain

00:01:47.569 --> 00:01:47.579 
differently and have lower pain

00:01:47.579 --> 00:01:50.420 
differently and have lower pain
thresholds<00:01:48.240> compared<00:01:48.659> to<00:01:48.780> normals<00:01:49.430> research

00:01:50.420 --> 00:01:50.430 
thresholds compared to normals research

00:01:50.430 --> 00:01:52.370 
thresholds compared to normals research
has<00:01:50.670> demonstrated<00:01:50.850> that<00:01:51.540> various<00:01:51.990> pain

00:01:52.370 --> 00:01:52.380 
has demonstrated that various pain

00:01:52.380 --> 00:01:54.200 
has demonstrated that various pain
related<00:01:52.740> processes<00:01:53.130> in<00:01:53.820> the<00:01:53.850> brain<00:01:54.060> and

00:01:54.200 --> 00:01:54.210 
related processes in the brain and

00:01:54.210 --> 00:01:57.709 
related processes in the brain and
spinal<00:01:54.840> cord<00:01:54.990> are<00:01:55.520> abnormal<00:01:56.520> in<00:01:56.729> fibromyalgia

00:01:57.709 --> 00:01:57.719 
spinal cord are abnormal in fibromyalgia

00:01:57.719 --> 00:02:01.280 
spinal cord are abnormal in fibromyalgia
but<00:01:58.619> more<00:01:58.950> work<00:01:59.159> remains<00:01:59.189> to<00:01:59.670> be<00:01:59.790> done<00:02:00.290> market

00:02:01.280 --> 00:02:01.290 
but more work remains to be done market

00:02:01.290 --> 00:02:03.740 
but more work remains to be done market
surveys<00:02:01.770> show<00:02:02.130> the<00:02:02.340> number<00:02:02.579> one<00:02:03.000> class<00:02:03.450> of

00:02:03.740 --> 00:02:03.750 
surveys show the number one class of

00:02:03.750 --> 00:02:06.760 
surveys show the number one class of
drugs<00:02:04.110> used<00:02:04.979> to<00:02:05.159> treat<00:02:05.390> fibromyalgia<00:02:06.390> is

00:02:06.760 --> 00:02:06.770 
drugs used to treat fibromyalgia is

00:02:06.770 --> 00:02:09.800 
drugs used to treat fibromyalgia is
non-steroidal<00:02:08.030> anti-inflammatory<00:02:09.030> drugs

00:02:09.800 --> 00:02:09.810 
non-steroidal anti-inflammatory drugs

00:02:09.810 --> 00:02:11.960 
non-steroidal anti-inflammatory drugs
since<00:02:10.649> fibromyalgia<00:02:11.400> is<00:02:11.430> not<00:02:11.760> an

00:02:11.960 --> 00:02:11.970 
since fibromyalgia is not an

00:02:11.970 --> 00:02:14.150 
since fibromyalgia is not an
inflammatory<00:02:12.510> disease<00:02:13.290> it<00:02:13.800> is<00:02:13.980> not

00:02:14.150 --> 00:02:14.160 
inflammatory disease it is not

00:02:14.160 --> 00:02:15.860 
inflammatory disease it is not
surprising<00:02:14.400> we<00:02:14.940> have<00:02:15.060> a<00:02:15.090> lot<00:02:15.330> of<00:02:15.360> treatment

00:02:15.860 --> 00:02:15.870 
surprising we have a lot of treatment

00:02:15.870 --> 00:02:18.710 
surprising we have a lot of treatment
failures<00:02:16.459> the<00:02:17.459> pharmaceutical<00:02:18.239> industry

00:02:18.710 --> 00:02:18.720 
failures the pharmaceutical industry

00:02:18.720 --> 00:02:20.300 
failures the pharmaceutical industry
knows<00:02:18.930> this<00:02:19.230> and<00:02:19.410> they<00:02:19.860> are<00:02:19.980> viewing

00:02:20.300 --> 00:02:20.310 
knows this and they are viewing

00:02:20.310 --> 00:02:22.970 
knows this and they are viewing
fibromyalgia<00:02:21.150> as<00:02:21.330> the<00:02:21.510> prototypical<00:02:22.410> central

00:02:22.970 --> 00:02:22.980 
fibromyalgia as the prototypical central

00:02:22.980 --> 00:02:26.059 
fibromyalgia as the prototypical central
pain<00:02:23.280> state<00:02:23.670> the<00:02:24.630> two<00:02:24.840> main<00:02:25.050> drug<00:02:25.349> classes<00:02:25.950> of

00:02:26.059 --> 00:02:26.069 
pain state the two main drug classes of

00:02:26.069 --> 00:02:28.970 
pain state the two main drug classes of
interest<00:02:26.430> are<00:02:26.580> the<00:02:27.120> dual<00:02:27.360> receptor<00:02:28.260> reuptake

00:02:28.970 --> 00:02:28.980 
interest are the dual receptor reuptake

00:02:28.980 --> 00:02:31.729 
interest are the dual receptor reuptake
inhibitors<00:02:29.610> like<00:02:29.849> duloxetine<00:02:30.569> or<00:02:31.080> cymbalta

00:02:31.729 --> 00:02:31.739 
inhibitors like duloxetine or cymbalta

00:02:31.739 --> 00:02:34.940 
inhibitors like duloxetine or cymbalta
and<00:02:31.950> the<00:02:32.700> anti-epileptic<00:02:33.630> drugs<00:02:33.950> like

00:02:34.940 --> 00:02:34.950 
and the anti-epileptic drugs like

00:02:34.950 --> 00:02:38.360 
and the anti-epileptic drugs like
pregabalin<00:02:35.670> or<00:02:36.060> lyrica<00:02:36.510> in<00:02:36.720> fact<00:02:37.680> pregabalin

00:02:38.360 --> 00:02:38.370 
pregabalin or lyrica in fact pregabalin

00:02:38.370 --> 00:02:40.699 
pregabalin or lyrica in fact pregabalin
has<00:02:38.760> shown<00:02:38.970> enough<00:02:39.239> efficacy<00:02:39.599> that<00:02:40.170> it<00:02:40.380> is<00:02:40.530> the

00:02:40.699 --> 00:02:40.709 
has shown enough efficacy that it is the

00:02:40.709 --> 00:02:43.699 
has shown enough efficacy that it is the
first<00:02:40.980> and<00:02:41.310> only<00:02:41.569> drug<00:02:42.569> approved<00:02:43.019> by<00:02:43.230> the<00:02:43.290> fda

00:02:43.699 --> 00:02:43.709 
first and only drug approved by the fda

00:02:43.709 --> 00:02:45.759 
first and only drug approved by the fda
for<00:02:43.830> the<00:02:44.130> treatment<00:02:44.430> of<00:02:44.670> fibromyalgia

00:02:45.759 --> 00:02:45.769 
for the treatment of fibromyalgia

00:02:45.769 --> 00:02:48.140 
for the treatment of fibromyalgia
therefore<00:02:46.769> in<00:02:47.010> the<00:02:47.250> future<00:02:47.610> with<00:02:47.940> new

00:02:48.140 --> 00:02:48.150 
therefore in the future with new

00:02:48.150 --> 00:02:50.720 
therefore in the future with new
insights<00:02:48.569> and<00:02:48.840> therapies<00:02:49.230> on<00:02:49.470> the<00:02:49.590> horizon<00:02:49.730> we

00:02:50.720 --> 00:02:50.730 
insights and therapies on the horizon we

00:02:50.730 --> 00:02:52.520 
insights and therapies on the horizon we
will<00:02:50.940> no<00:02:51.120> longer<00:02:51.150> need<00:02:51.720> to<00:02:51.959> prefer<00:02:52.319> our

00:02:52.520 --> 00:02:52.530 
will no longer need to prefer our

00:02:52.530 --> 00:02:54.140 
will no longer need to prefer our
fibromyalgia<00:02:53.430> patients<00:02:53.640> to<00:02:54.030> the

00:02:54.140 --> 00:02:54.150 
fibromyalgia patients to the

00:02:54.150 --> 00:02:57.530 
fibromyalgia patients to the
rheumatologist<00:02:54.930> that's<00:02:55.799> my<00:02:56.069> opinion<00:02:56.400> i'm<00:02:56.790> dr.

00:02:57.530 --> 00:02:57.540 
rheumatologist that's my opinion i'm dr.

00:02:57.540 --> 00:02:59.570 
rheumatologist that's my opinion i'm dr.
george<00:02:57.780> Griffing<00:02:58.290> professor<00:02:58.950> of<00:02:59.069> medicine<00:02:59.340> at

00:02:59.570 --> 00:02:59.580 
george Griffing professor of medicine at

00:02:59.580 --> 00:03:02.120 
george Griffing professor of medicine at
st.<00:02:59.849> louis<00:03:00.060> university<00:03:00.239> and<00:03:00.870> editor<00:03:01.709> in<00:03:01.860> chief

00:03:02.120 --> 00:03:02.130 
st. louis university and editor in chief

00:03:02.130 --> 00:03:10.090 
st. louis university and editor in chief
of<00:03:02.340> internal<00:03:02.700> medicine<00:03:03.000> for<00:03:03.599> e<00:03:03.810> medicine

00:03:10.090 --> 00:03:10.100 

00:03:10.100 --> 00:03:12.160 

you

